Sistema para la inclusión de pacientes en ensayos clínicos en tiempo real

the molecular immunology center has developed a series of biomolecules for cancer treatment. with a forecast for the inclusion of 3000 patients per year in clinical trials, the aim of this study was to find a way to control that process. the data management group, in conjunction with the national coordinating center for clinical trials, began enrolling patients in clinical trials by phone and through email. in 2010 the web site (http://cimensayossp/clinica/default.aspx) was created to include clinical trials, which is a powerful tool to control the status of patient inclusion. it allowed reporting the number of inclusions and to know the actual inclusion rate in each trial to take action and improve the planned inclusion. in addition, it ensures no delays in the delivery of the investigational product.